ALPA

ALPA LABORATORIES

Small Cap BSE: 532878 NSE: ALPA
₹54.2
-1.45 (-2.61%)
As on 01 December, 2022 | 05:51

Alpa Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ALPA LABORATORIES

Start SIP

Alpa Laboratories Share Price

Alpa Laboratories Share Returns

  • Over 1 Month -7.11%
  • Over 3 Month -13.42%
  • Over 6 Month -14.58%
  • Over 1 Year 1.31%

Alpa Laboratories Key Statistics

P/E Ratio 23.6
PEG Ratio -0.4
Market Cap Cr 114
Price to Book Ratio 0.9
EPS 3.7
Dividend 0
Relative Strength Index 48.26
Money Flow Index 65.75
MACD Signal -1.33
Average True Range 3.17

Alpa Laboratories Investment Rating

  • Master Rating:
  • Alpa Laboratories has an operating revenue of Rs. 90.46 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 17% is great, ROE of 11% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 14222629263225
Operating Expenses Qtr Cr 19212726232924
Operating Profit Qtr Cr -61-14431
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 0050004
Net Profit Qtr Cr 03-4566-2

Alpa Laboratories Technicals

EMA & SMA

Current Price
54.2
-1.45 (-2.61%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 55.55
  • 50 Day
  • 57.7
  • 100 Day
  • 60.63
  • 200 Day
  • 65.84
  • 20 Day
  • 55.6
  • 50 Day
  • 58.05
  • 100 Day
  • 60.62
  • 200 Day
  • 65.8

Alpa Laboratories Resistance and Support

PIVOT
₹56.1
Resistance
First Resistance 57.05
Second Resistance 58.45
Third Resistance 59.4
RSI 48.26
MFI 65.75
MACD Single Line -1.33
MACD -1.04
Support
First Resistance 54.7
Second Resistance 53.75
Third Resistance 52.35

Alpa Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 86,322 5,091,272 58.98
Week 62,325 3,725,800 59.78
1 Month 97,431 4,706,892 48.31
6 Month 62,595 3,249,939 51.92

Alpa Laboratories Result Highlights

Alpa Laboratories Synopsis

NSE-Medical-Generic Drugs

Alpa Laboratories Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 112.27 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2022. Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446.
Market Cap 117
Sales 91
Shares in Float 0.90
No of funds 1
Yield
Book Value 0.89
U/D Vol ratio 0.6
LTDebt / Equity 2
Alpha 0.03
Beta 1.45

Alpa Laboratories

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 57.29%57.29%57.29%
Foreign Portfolio Investors 0.14%0.21%0.56%
Individual Investors 37.72%37.93%37.18%
Others 4.85%4.57%4.97%

Alpa Laboratories Management

Name Designation
Mr. Mahendra Singh Chawla Chairman
Mr. Paresh Chawla Managing Director
Mr. Devendra Baheti Independent Director
Mr. Sharad Chand Lunawat Independent Director
Mr. Krishna Das Malani Independent Director
Mrs. Jyoti Jain Independent Director
Mr. Pravin Shah Director

Alpa Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alpa Laboratories Corporate Action

Date Purpose Remarks
2022-11-14 Quarterly Results
2022-08-13 Quarterly Results
2022-05-28 Audited Results
2022-02-14 Quarterly Results
2021-11-13 Quarterly Results

Alpa Laboratories FAQs

What is Share Price of Alpa Laboratories ?

Alpa Laboratories share price is ₹54 As on 01 December, 2022 | 05:37

What is the Market Cap of Alpa Laboratories ?

The Market Cap of Alpa Laboratories is ₹114 Cr As on 01 December, 2022 | 05:37

What is the P/E ratio of Alpa Laboratories ?

The P/E ratio of Alpa Laboratories is 23.6 As on 01 December, 2022 | 05:37

What is the PB ratio of Alpa Laboratories ?

The PB ratio of Alpa Laboratories is 0.9 As on 01 December, 2022 | 05:37

Q2FY23